Log In
BCIQ
Print this Print this
 

Renitec, enalapril

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionAngiotensin-converting enzyme (ACE) inhibitor
Molecular Target Angiotensin-converting enzyme (ACE)
Mechanism of ActionAngiotensin-converting enzyme (ACE) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat hypertension
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/25/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today